Reduce movement slowness and fatigue
- Trial ID
- NCT06883266
- Official Title
- Transcranial Direct Current Stimulation (tDCS) to Improve Motor Function and Motor Fatigue in Parkinson's Patients
- Goal
- Reduce movement slowness and fatigue
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Sanford Health
- Study Type
- INTERVENTIONAL
- Enrollment
- 64 participants
- Conditions
- Parkinsons Disease (PD)
- Interventions
- transcranial direct current stimulation (tDCS), Sham (No Treatment)
Plain-Language Summary
The goal is to improve motor function and reduce motor fatigue in people with Parkinson's, targeting the slowness and tiring that make daily activities harder. It uses transcranial direct current stimulation, a gentle, noninvasive electrical current applied to the scalp to boost excitability in motor brain areas and help recalibrate the circuits that control movement; sessions are compared to sham (no treatment), and the approach is intended to be used alongside your usual Parkinson's medications rather than replace them. The trial is looking for adults with a clinical PD diagnosis who have at least two of the core motor signs and can consent, and it excludes people with dementia (MOCA < 21), deep brain stimulation, psychosis, multiple sclerosis, stroke, COPD, or congestive heart failure.
Locations
- Sanford Brain and Spine Center, Fargo, North Dakota, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying transcranial direct current stimulation (tDCS). The goal is to improve motor function and reduce motor fatigue in people with Parkinson's, targeting the slowness and tiring that make daily activities harder. It uses transcranial direct current stimulation, a gentle, noninvasive electrical current applied to the scalp to boost excitability in motor brain areas and help recalibrate the circuits that control movement; sessions are compared to sham (no treatment), and the approach is intended to be used alongside your usual Parkinson's medications rather than replace them. The trial is looking for adults with a clinical PD diagnosis who have at least two of the core motor signs and can consent, and it excludes people with dementia (MOCA < 21), deep brain stimulation, psychosis, multiple sclerosis, stroke, COPD, or congestive heart failure.
- Who can participate?
- Eligibility criteria vary. Check the full listing on ClinicalTrials.gov for detailed inclusion and exclusion criteria.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 2 years.